Core A: Administration oversees the entire DIAN project: coordinating activities of the other Cores and subcontractors, managing and supporting the DIAN Steering Committee, seeking and implementing feedback from the External Advisory Committee, interacting with the NIA's scientific and administrative liaisons, and managing financial affairs overall and with individual clinical sites. It is led by the DIAN Principal Investigator Dr. Randall Bateman, with the assistance of Associate Directors Drs. John Morris, David Holtzman, and Celeste Karch, and Deputy Director Laura Swisher. DIAN was designed to establish an international, multisite collaborative study using comprehensive, intensive, uniform, standardized protocols in a rare group of participants at risk for autosomal dominant Alzheimer's disease (ADAD). DIAN protocols harmonize imaging and biomarker procedures with the Alzheimer's Disease Neuroimaging Initiative (ADNI) and clinical and psychometric procedures with the National Alzheimer's Coordinating Center (NACC) to make future comparisons with sporadic AD possible. The highly successful DIAN study now includes 20 performance sites, including 12 international sites, 9 of which are self-funded and follow DIAN protocols, with the NIH supporting central functions such as the Cores. The Administration Core manages the subcontracts for all performance sites and leads communication with and between sites, monitors site performance, and conducts site training and initiation visits for new sites. The Administration Core has continued to support aims of the DIAN study since its inception, including maintaining a registry for ADAD families, recruiting and retaining participants, maintaining an extensive database and biospecimen repository, and providing genetic counseling and testing to DIAN participants who wish to learn their mutation status. In this renewal, the Administration Core will lead the harmonization of the DIAN observational study (DIAN-OBS), DIAN Trials Unit (DIAN-TU), and DIAN Expanded Registry (DIAN- EXR), including working with all Cores and performance sites to implement ICH GCP and 21 CFR Part 11 compliance. The synergy among the three DIAN studies will facilitate efficient sharing of data and resources and increase the volume and quality of DIAN-OBS data. Additionally, the Administration Core will support the newly established Cognition Core in integrating its directives. The Administration Core will also closely coordinate, support and monitor the implementation of the three DIAN Scientific Projects. Through leadership, collaboration, and extensive coordination, the Administration Core will continue to accomplish DIAN's aims and scientific initiatives, and ensure that DIAN continues to be a cohesive, rigorous, and innovative study.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AG032438-09
Application #
10017823
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2008-09-15
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Li, Zeran; Del-Aguila, Jorge L; Dube, Umber et al. (2018) Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Med 10:43
Wang, Guoqiao; Berry, Scott; Xiong, Chengjie et al. (2018) A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Stat Med 37:3047-3055
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Gordon, Brian A; Blazey, Tyler M; Su, Yi et al. (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol 17:241-250
Müller, Stephan; Preische, Oliver; Sohrabi, Hamid R et al. (2018) Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimers Dement 14:1427-1437
Villeneuve, Sylvia; Vogel, Jacob W; Gonneaud, Julie et al. (2018) Proximity to Parental Symptom Onset and Amyloid-? Burden in Sporadic Alzheimer Disease. JAMA Neurol 75:608-619
Lim, Yen Ying; Hassenstab, Jason; Goate, Alison et al. (2018) Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease. Ann Neurol 84:424-435
Su, Yi; Flores, Shaney; Hornbeck, Russ C et al. (2018) Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406-416
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53

Showing the most recent 10 out of 97 publications